[Laboratory and clinical studies of cefprozil in pediatric field].

Author: AokiS, NishimuraT, TabukiK, TakagiM

Paper Details 
Original Abstract of the Article :
Laboratory and clinical studies were done on cefprozil (CFPZ, BMY-28100). The results are summarized as follows. CFPZ was administered through the oral route to 2 children at a single dose of 7.5 mg/kg. After administration, peak serum levels of CFPZ obtained in the 2 cases were 6.71 micrograms/ml a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1494239

データ提供:米国国立医学図書館(NLM)

Cefprozil: A New Hope for Pediatric Infections

In the realm of pediatric medicine, finding effective and safe treatments for bacterial infections is a constant challenge. This study explores the potential of cefprozil (CFPZ), an antibiotic, in treating a range of bacterial infections in children. It's like searching for a rare desert flower with potent healing properties.

The researchers conducted both laboratory and clinical studies to evaluate the efficacy and safety of CFPZ in children. This multi-pronged approach is like exploring a desert landscape from both above and below, gaining a comprehensive understanding of its characteristics.

Cefprozil Shows Promise in Treating Pediatric Infections

The study found that CFPZ was effective in treating various bacterial infections in children, with a high success rate. This discovery is like finding a hidden oasis in the desert, offering a source of relief and healing.

A Safe and Effective Treatment Option

The researchers noted that CFPZ was generally well-tolerated by children, with minimal side effects. This finding is like discovering a path through a desert, safe and navigable for those seeking a cure.

Dr. Camel's Conclusion

This study provides valuable insights into the potential of cefprozil as a safe and effective treatment option for various bacterial infections in children. It offers hope for better management of childhood illnesses, paving the way for a healthier future for our youngest explorers.

Date :
  1. Date Completed 1993-03-11
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

1494239

DOI: Digital Object Identifier

1494239

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.